Cargando…

Metabolic health phenotype better predicts subclinical atherosclerosis than body mass index-based obesity phenotype in the non-alcoholic fatty liver disease population

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD), especially lean NAFLD is associated with an increased risk of atherosclerotic cardiovascular disease (CVD). It is not currently known which clinical phenotypes of NAFLD contribute most to individual subclinical atherosclerosis risk. We examined...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yaqin, Yuan, Ting, Deng, Shuwen, Zhu, Xiaoling, Deng, Yuling, Liu, Xuelian, Liu, Lei, Wang, Changfa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Nutrition
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546180/ https://www.ncbi.nlm.nih.gov/pubmed/37794971 http://dx.doi.org/10.3389/fnut.2023.1104859

Ejemplares similares

Association between non-alcoholic fatty liver disease and metabolically healthy deterioration across different body shape phenotypes at baseline and change patterns
por: Lei, Liu, et al.
Publicado: (2022)

Transition patterns of metabolic dysfunction-associated fatty liver disease status in relation to arterial stiffness progression: a health check-up cohort study
por: Liu, Lei, et al.
Publicado: (2023)

Expanding the phenotypic spectrum of non-alcoholic fatty liver disease and hypertriglyceridemia
por: Meroni, Marica, et al.
Publicado: (2022)

Higher S-adenosylhomocysteine and lower ratio of S-adenosylmethionine to S-adenosylhomocysteine were more closely associated with increased risk of subclinical atherosclerosis than homocysteine
por: Xiao, Jinghe, et al.
Publicado: (2022)

Polydatin, A Glycoside of Resveratrol, Is Better Than Resveratrol in Alleviating Non-alcoholic Fatty Liver Disease in Mice Fed a High-Fructose Diet
por: Zhao, Guangshan, et al.
Publicado: (2022)

The atherogenic index of plasma: A novel factor more closely related to non-alcoholic fatty liver disease than other lipid parameters in adults
por: Liu, Jia, et al.
Publicado: (2022)

Baseline level and change trajectory of the triglyceride-glucose index in relation to the development of NAFLD: a large population-based cohort study
por: Wang, Yaqin, et al.
Publicado: (2023)

Subclinical Atherosclerosis and Obesity Phenotypes Among Mexican Americans
por: Laing, Susan T., et al.
Publicado: (2015)

Association Between Body Size Phenotypes and Subclinical Atherosclerosis
por: Rossello, Xavier, et al.
Publicado: (2020)

Prediction of subclinical atherosclerosis in low Framingham risk score individuals by using the metabolic syndrome criteria and insulin sensitivity index
por: Huang, Benjamin, et al.
Publicado: (2022)

Association of non-alcoholic fatty liver disease with cardiovascular disease and subclinical atherosclerosis
por: Sao, Rahul, et al.
Publicado: (2017)

Associations of Nutritional, Lifestyle, and Metabolic Factors With Non-alcoholic Fatty Liver Disease: An Umbrella Review With More Than 380,000 Participants
por: Xia, Yang, et al.
Publicado: (2021)

Body Roundness Index and Waist–Hip Ratio Result in Better Cardiovascular Disease Risk Stratification: Results From a Large Chinese Cross-Sectional Study
por: Li, Ying, et al.
Publicado: (2022)

Relationship between the novel and traditional anthropometric indices and subclinical atherosclerosis evaluated by carotid intima-media thickness (c-IMT)
por: Costo-Muriel, Clara, et al.
Publicado: (2023)

Gut microbial response to host metabolic phenotypes
por: Hou, Jinliang, et al.
Publicado: (2022)

Dietary inflammatory index and risk of non-alcoholic fatty liver disease and advanced hepatic fibrosis in US adults
por: Zhang, Zhongmian, et al.
Publicado: (2023)

Impact of FADS gene variation and dietary fatty acid exposure on biochemical and anthropomorphic phenotypes in a Hispanic/Latino cohort
por: Sergeant, Susan, et al.
Publicado: (2023)

Association between dietary inflammatory index and atherosclerosis cardiovascular disease in U.S. adults
por: Zhang, Jie, et al.
Publicado: (2023)

Dietary fatty acids and risk of non-alcoholic steatohepatitis: A national study in the United States
por: Lu, Xiao-Ting, et al.
Publicado: (2022)

Complex Dietary Topologies in Non-alcoholic Fatty Liver Disease: A Network Science Analysis
por: Xia, Yang, et al.
Publicado: (2020)

Association between insomnia phenotypes and subclinical myocardial injury: the Multi-Ethnic Study of Atherosclerosis
por: Sigurdardottir, Fjola D, et al.
Publicado: (2022)

Gut microbiota–mitochondrial inter-talk in non-alcoholic fatty liver disease
por: Zhang, Qi, et al.
Publicado: (2022)

CircRNA-mediated regulation of brown adipose tissue adipogenesis
por: Liu, Kaiqing, et al.
Publicado: (2022)

The effects of supplementation of probiotics, prebiotics, or synbiotics on patients with non-alcoholic fatty liver disease: A meta-analysis of randomized controlled trials
por: Xing, Wenmin, et al.
Publicado: (2022)

Selenotranscriptome Network in Non-alcoholic Fatty Liver Disease
por: Day, Kaitlin, et al.
Publicado: (2021)

The effect of omega-3 fatty acids on alcohol-induced damage
por: Serrano, Maitane, et al.
Publicado: (2023)

Is mushroom polysaccharide extract a better fat replacer than dried mushroom powder for food applications?
por: See Toh, Cheryl Jie Yi, et al.
Publicado: (2023)

Higher anthocyanin intake is associated with a lower risk of non-alcoholic fatty liver disease in the United States adult population
por: Xiang, Shuai, et al.
Publicado: (2023)

Effects of probiotics on non-alcoholic fatty liver disease: a review of human clinical trials
por: Cao, Chujin, et al.
Publicado: (2023)

Editorial: Nutrition in prevention and management of non-alcoholic fatty liver disease
por: Kouvari, Matina, et al.
Publicado: (2023)

Editorial: Gut Microbial Response to Host Metabolic Phenotypes
por: Yin, Jie, et al.
Publicado: (2022)

Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis
por: Fadaei, Reza, et al.
Publicado: (2018)

Association of anti-oxidative capacity of HDL with subclinical atherosclerosis in subjects with and without non-alcoholic fatty liver disease
por: Karami, Sara, et al.
Publicado: (2021)

Severe, but not mild to moderate, non-alcoholic fatty liver disease associated with increased risk of subclinical coronary atherosclerosis
por: Hsiao, Chia-Chi, et al.
Publicado: (2021)

Fat-Free Mass Index, Visceral Fat Level, and Muscle Mass Percentage Better Explain Deviations From the Expected Value of Aortic Pressure and Structural and Functional Arterial Properties Than Body Fat Indexes
por: Gómez-García, Mariana, et al.
Publicado: (2022)

Carotenoids in orange carrots mitigate non-alcoholic fatty liver disease progression
por: Balbuena, Emilio, et al.
Publicado: (2022)

Mini review: STING activation during non-alcoholic fatty liver disease
por: Li, Honggui, et al.
Publicado: (2023)

Research progress on the therapeutic effects of polysaccharides on non-alcoholic fatty liver diseases
por: Hu, Yu-long, et al.
Publicado: (2023)

Effects of cholesterol-lowering probiotics on non-alcoholic fatty liver disease in FXR gene knockout mice
por: Yang, Minghua, et al.
Publicado: (2023)

Effects of beer, wine, and baijiu consumption on non-alcoholic fatty liver disease: Potential implications of the flavor compounds in the alcoholic beverages
por: Zhou, Yabin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kmt3616fgfu3fqeqv8vipeqvcq